SCHEMBL23488486

SCHEMBL23488486

CC1O[C@H](COC(=O)c2cc(Cl)cc(OCc3ccccc3)c2)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HIF1A Q16665 2/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNA5 P30532 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
MAOB P27338 4/20 0.39
TDP1 Q9NUW8 1/20 0.38
NR4A2 P43354 3/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
TYMP P19971 1/20 0.38
MAOA P21397 2/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488500 1.00 MRGPRX4 (0.42) MRGPRX4MEN1KMT2AHIF1ACHRNB2
SCHEMBL23488155 0.89 TDP1 (0.45) MRGPRX4MEN1KMT2AHIF1ACHRNB2
SCHEMBL23488498 0.87 MAOB (0.52) MRGPRX4MEN1KMT2AHIF1ACHRNB2
SCHEMBL23488604 0.86 CHRNB2 (0.53) MEN1KMT2AHIF1ACHRNB2CHRNA5
SCHEMBL23488173 0.86 CHRNB2 (0.53) MEN1KMT2AHIF1ACHRNB2CHRNA5
SCHEMBL23488136 0.84 XDH (0.42) MRGPRX4MEN1KMT2AHIF1AMAOB
SCHEMBL23488499 0.83 MRGPRX4 (0.43) MRGPRX4MEN1KMT2AHIF1ACHRNB2
SCHEMBL23488137 0.83 XDH (0.41) MRGPRX4MEN1KMT2AHIF1ACHRNB2
SCHEMBL23488129 0.81 KDM4E (0.46) MEN1KMT2ATDP1ALDH1A1
SCHEMBL23488693 0.81 KDM4E (0.46) MEN1KMT2ATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MRGPRX4 87/4885MEN1 1749/4885KMT2A 4555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.